Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/8438426

Download in:

View as

General Info

PMID
8438426